PT2912465T - Metilglioxal como marcador para o cancro - Google Patents

Metilglioxal como marcador para o cancro

Info

Publication number
PT2912465T
PT2912465T PT137830733T PT13783073T PT2912465T PT 2912465 T PT2912465 T PT 2912465T PT 137830733 T PT137830733 T PT 137830733T PT 13783073 T PT13783073 T PT 13783073T PT 2912465 T PT2912465 T PT 2912465T
Authority
PT
Portugal
Prior art keywords
methylglyoxal
marker
cancer
Prior art date
Application number
PT137830733T
Other languages
English (en)
Inventor
Belpomme Dominique
Irigaray Philippe
Original Assignee
Association Pour La Rech Therapeutique Anti Cancereuse
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Association Pour La Rech Therapeutique Anti Cancereuse filed Critical Association Pour La Rech Therapeutique Anti Cancereuse
Publication of PT2912465T publication Critical patent/PT2912465T/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
PT137830733T 2012-10-25 2013-10-25 Metilglioxal como marcador para o cancro PT2912465T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2012/071163 WO2014063743A1 (en) 2012-10-25 2012-10-25 Methylglyoxal as a marker of cancer

Publications (1)

Publication Number Publication Date
PT2912465T true PT2912465T (pt) 2018-01-25

Family

ID=47074733

Family Applications (1)

Application Number Title Priority Date Filing Date
PT137830733T PT2912465T (pt) 2012-10-25 2013-10-25 Metilglioxal como marcador para o cancro

Country Status (11)

Country Link
US (1) US20150301056A1 (pt)
JP (1) JP6543193B2 (pt)
CN (1) CN104854458B (pt)
CA (1) CA2889110A1 (pt)
DK (1) DK2912465T3 (pt)
ES (1) ES2656896T3 (pt)
MA (1) MA38042B2 (pt)
PT (1) PT2912465T (pt)
RU (1) RU2666255C2 (pt)
TN (1) TN2015000161A1 (pt)
WO (2) WO2014063743A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106769349B (zh) * 2017-01-06 2020-01-21 上海君联医疗设备有限公司 血液中异常糖基化蛋白细胞的检测方法
CN108426996B (zh) * 2017-02-15 2020-09-15 江苏美正生物科技有限公司 一种3-甲基喹噁啉-2-羧酸残留的快速检测试剂盒及其制备方法和应用
GB2566681B (en) * 2017-09-14 2021-07-28 Ip2Ipo Innovations Ltd Biomarker
CN108061802A (zh) * 2017-12-08 2018-05-22 武汉科技大学 一种通过血液检测评定乳腺癌的方法
WO2020112027A1 (en) * 2018-11-28 2020-06-04 National University Of Singapore Method of detecting cancer and/or tuberculosis
CN110604823B (zh) * 2019-10-21 2020-10-20 兰州大学 一种快速筛选抗糖化和/或抗衰老物质的方法
CN113376199A (zh) * 2021-05-12 2021-09-10 兰立生物科技(苏州)有限公司 一种用于癌症检测的生化分析检测系统
CN114496306B (zh) * 2022-01-28 2022-12-20 北京大学口腔医学院 基于机器学习的预后生存阶段预测方法和系统
US20220206017A1 (en) * 2022-03-18 2022-06-30 Joel Steven Goldberg Aerobic glycolysis and hypermetabolic states

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2007073005A1 (ja) * 2005-12-22 2009-06-04 学校法人慶應義塾 メチル基転移反応調節物質
US8026049B2 (en) * 2007-03-23 2011-09-27 Wisconsin Alumni Research Foundation Noninvasive measurement and identification of biomarkers in disease state
JP4836926B2 (ja) * 2007-11-12 2011-12-14 株式会社日本トリム 糖分解代謝物の測定方法
JP5787339B2 (ja) * 2009-12-28 2015-09-30 学校法人福岡大学 糖尿病前症の検査方法
DE112012000990B4 (de) * 2011-02-24 2024-06-27 Aspira Women's Health Inc. (n.d.Ges.d.Staates Delaware) Biomarker-Panels, Diagnostische Verfahren und Testkits für Eierstockkrebs

Also Published As

Publication number Publication date
MA38042B2 (fr) 2019-11-29
MA38042A3 (fr) 2018-03-30
RU2666255C2 (ru) 2018-09-06
WO2014063743A1 (en) 2014-05-01
JP2016500821A (ja) 2016-01-14
CA2889110A1 (en) 2014-05-01
US20150301056A1 (en) 2015-10-22
JP6543193B2 (ja) 2019-07-10
WO2014064283A1 (en) 2014-05-01
ES2656896T3 (es) 2018-02-28
TN2015000161A1 (en) 2016-10-03
RU2015119512A (ru) 2016-12-20
CN104854458A (zh) 2015-08-19
CN104854458B (zh) 2018-02-09
MA38042A2 (fr) 2017-02-28
DK2912465T3 (en) 2018-01-15

Similar Documents

Publication Publication Date Title
HK1205697A1 (en) Prodrugs of hydroxyl-comprising drugs
EP2912485A4 (en) POSITIONING
EP2895876A4 (en) LOCATION OF UNDERGROUND MARKERS
PT2912465T (pt) Metilglioxal como marcador para o cancro
PL2819982T3 (pl) Proleki witaminy k
ZA201500656B (en) Marker vaccine
HK1203933A1 (en) Thienopyrimidine compounds
GB201205164D0 (en) Pharmaceutical compounds
EP2706946A4 (en) POSITIONING MARKING
HK1197062A1 (en) Chromene compound
EP2818870A4 (en) COMBINED MARKER FOR DETERMINING THE SENSITIVITY TO ANTICREMENT
HK1200538A1 (en) A tumor marker
HK1216619A1 (zh) 藥物化合物
EP2825198A4 (en) THERAPEUTIC AGAINST CANCER
GB2503293B (en) Make a mask
PL2877153T3 (pl) Preparat witaminowy
SG11201406294YA (en) Melanin production inhibitor
GB201202027D0 (en) Pharmaceutical compounds
HK1155034A2 (en) Marker pen
IL238866A0 (en) Saquinavir nitrate ester for immunomodulation
PL2912465T3 (pl) Metyloglioksal jako marker nowotworu
GB201106870D0 (en) Marker
HK1211853A1 (en) Melanin production inhibitor
GB201222952D0 (en) Treatent of cancer
GB201117731D0 (en) Marker